BioArctic AB Forecast, price target & analysts
BioArctic AB Target price 2026 - Analyst rating & recommendation
BioArctic AB Classifications & Recommendation
BioArctic AB Price Target
| Target Price | kr357.00 |
| Price | kr305.60 |
| Potential |
16.82%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target BioArctic AB 2027 .
The average BioArctic AB target price is kr357.00.
This is
16.82%
register free of charge
kr388.50
27.13%
register free of charge
kr282.80
7.46%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend BioArctic AB to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioArctic AB stock has an average upside potential 2027 of
16.82%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 2.00 | 1.50 |
| 676.81% | 25.17% | |
| EBITDA Margin | 69.08% | 21.60% |
| 181.22% | 68.73% | |
| Net Margin | 51.14% | 28.47% |
| 174.32% | 44.33% |
5 Analysts have issued a sales forecast BioArctic AB 2026 . The average BioArctic AB sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an BioArctic AB EBITDA forecast 2026. The average BioArctic AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 BioArctic AB Analysts have issued a net profit forecast 2026. The average BioArctic AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 11.55 | 4.80 |
| 677.50% | 58.44% | |
| P/E | 63.66 | |
| EV/Sales | 17.05 |
4 Analysts have issued a BioArctic AB forecast for earnings per share. The average BioArctic AB EPS is
This results in the following potential growth metrics and future valuations:
Current BioArctic AB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Jun 22 2026 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Jun 21 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | May 22 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | May 21 2026 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Feb 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Jun 22 2026 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Jun 21 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
May 22 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
May 21 2026 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Feb 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
